Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis

European Respiratory Journal

Volumn 41, Issue 6, 2013, Pages 1324-1330

  Patel, Nina M ^a,b   Kawut, Steven M ^c   Jelic, Sanja ^a   Arcasoy, Selim M ^a,b   Lederer, David J ^a,b   Borczuk, Alain C ^d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

DNA microarray; Laser capture microdissection; Pulmonary arterial hypertension; Usual interstitial pneumonia

Indexed keywords

RNA; WNT PROTEIN; TRANSCRIPTOME;

ADULT; APOPTOSIS; ARTERIOLE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; LABORATORY DEVICE; LASER CAPTURE MICRODISSECTION; LUNG BLOOD VESSEL; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RNA HYBRIDIZATION; VASCULAR SMOOTH MUSCLE; WNT SIGNALING PATHWAY; AGED; CASE CONTROL STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ARTERIOLES; CASE-CONTROL STUDIES; CELL PROLIFERATION; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTOME;

EID: 84878805652     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.0084112     Document Type: Article

References (31)

1. Patel NM, Lederer DJ, Borczuk AC, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007; 132: 998-1006.
2. Nathan SD, Shlobin OA, Ahmad S, et al. Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 2008; 76: 288-294.
3. Nathan SD, Shlobin OA, Ahmad S, et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131: 657-663. (Pubitemid 46446854)
4. Rajkumar R, Konishi K, Richards TJ, et al. Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension. Am J Physiol Heart Circ Physiol 2010; 298: H1235-H1248.
5. Gagermeier J, Dauber J, Yousem S, et al. Abnormal vascular phenotypes in patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension. Chest 2005; 128: Suppl. 6, 601S. (Pubitemid 43054149)
6. Patel NM, Kawut SM, Powell CA, et al. Gene expression profiling of pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF). Am J Respir Crit Care Med 2008; 177.
7. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
8. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American thoracic society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
9. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S55-S66.
10. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl. 1, S43-S54.
11. Krotova K, Patel JM, Block ER, et al. Hypoxic upregulation of arginase II in human lung endothelial cells. Am J Physiol Cell Physiol 2010; 299: C1541-C1548.
12. Mura M, Anruka M, Yun Z, et al. Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosis. Chest 2012; 141: 661-673.
13. Rocnik EF, Liu P, Sato K, et al. The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J Biol Chem 2006; 281: 22855-22864.
14. Ask K, Martin GE, Kolb M, et al. Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls. Proc Am Thorac Soc 2006; 3: 389-393. (Pubitemid 43845418)
15. Liu P, Lu J, Cardoso WV, et al. The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase. Mol Biol Cell 2008; 19: 248-261. (Pubitemid 351186150)
16. Marrero MB, Schieffer B, Li B, et al. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 1997; 272: 24684-24690. (Pubitemid 27418687)
17. Banes AK, Shaw SM, Tawfik A, et al. Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin. Am J Physiol Cell Physiol 2005; 288: C805-C812. (Pubitemid 40395058)
18. Woods M, Wood EG, Bardswell SC, et al. Role for nuclear factor-κB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Mol Pharmacol 2003; 64: 923-931. (Pubitemid 37153061)
19. Dumler I, Kopmann A, Weis A, et al. Urokinase activates the JAK/STAT signal transduction pathway in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 1999; 19: 290-297. (Pubitemid 29072741)
20. Dumler I, Kopmann A, Wagner K, et al. Urokinase induces activation and formation of STAT4 and STAT1-STAT2 complexes in human vascular smooth muscle cells. J Biol Chem 1999; 274: 24059-24065.
21. Courtwright A, Siamakpour-Reihani S, Arbiser JL, et al. Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway. Cancer Res 2009; 69: 4621-4628.
22. Laumanns IP, Fink L, Wilhelm J, et al. The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 2009; 40: 683-691.
23. Subramaniam M, Hawse JR, Johnsen SA, et al. Role of TIEG1 in biological processes and disease states. J Cell Biochem 2007; 102: 539-548. (Pubitemid 47557409)
24. Warke VG, Nambiar MP, Krishnan S, et al. Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6. J Biol Chem 2003; 278: 14812-14819. (Pubitemid 36799807)
25. Santiago FS, Lowe HC, Bobryshev YV, et al. Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fibroblast growth factor-2. J Biol Chem 2001; 276: 41143-41149.
26. Beck K, Wu BJ, Ni J, et al. Interplay between heme oxygenase-1 and the multifunctional transcription factor Yin Yang 1 in the inhibition of intimal hyperplasia. Circ Res 2010; 107: 1490-1497.
27. Achcar RO, Demura Y, Rai PR, et al. Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension. Chest 2006; 129: 696-705.
28. Vancheri C, Failla M, Crimi N, et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 2010; 35: 496-504.
29. Masri FA, Xu W, Comhair SA, et al. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2007; 293: L548-L554. (Pubitemid 47358814)
30. Shorr AF, Wainright JL, Cors CS, et al. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007; 30: 715-721. (Pubitemid 351194832)
31. Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105-111.